Allele-Specific Non-CG DNA Methylation Marks Domains of Active Chromatin in Female Mouse Brain

Total Page:16

File Type:pdf, Size:1020Kb

Allele-Specific Non-CG DNA Methylation Marks Domains of Active Chromatin in Female Mouse Brain Allele-specific non-CG DNA methylation marks domains of active chromatin in female mouse brain Christopher L. Keowna, Joel B. Berletchb, Rosa Castanonc, Joseph R. Neryc, Christine M. Distecheb,d, Joseph R. Eckerc,e, and Eran A. Mukamela,1 aDepartment of Cognitive Science, University of California, San Diego, CA 92037; bDepartment of Pathology, University of Washington, Seattle, WA 98195; cGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; dDepartment of Medicine, University of Washington, Seattle, WA 98195; and eHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037 Edited by Paul D. Soloway, Cornell University, Ithaca, NY, and accepted by Editorial Board Member Andrew G. Clark December 20, 2016 (received for review July 21, 2016) DNA methylation at gene promoters in a CG context is associated correlated with high or low levels of DNA methylation at CG with transcriptional repression, including at genes silenced on the dinucleotides (mCG) in promoter regions, respectively (10). How- inactive X chromosome in females. Non-CG methylation (mCH) is a ever, different epigenetic profiles may be associated with XCI and distinct feature of the neuronal epigenome that is differentially escape from XCI in the brain because the DNA methylation distributed between males and females on the X chromosome. landscape of neurons is distinct from other cell types. In particular, However, little is known about differences in mCH on the active neurons accumulate methylation at millions of genomic cytosines in (Xa) and inactive (Xi) X chromosomes because stochastic CA and CT dinucleotides during postnatal brain development be- X-chromosome inactivation (XCI) confounds allele-specific epige- ginning at 1 wk of age in mice (6, 11). This non-CG methylation nomic profiling. We used whole-genome bisulfite sequencing in a correlates with reduced gene expression and inactivation of distal mouse model with nonrandom XCI to examine allele-specific DNA regulatory elements in a highly cell type-specific manner (12). Al- methylation in frontal cortex. Xi was largely devoid of mCH, though the functional relevance of non-CG methylation whereas Xa contained abundant mCH similar to the male X (mCH) is unclear, it is bound by the transcriptional repressor chromosome and the autosomes. In contrast to the repressive methyl-CpG binding protein 2 (MeCP2) as neurons mature, association of DNA methylation at CG dinucleotides (mCG), mCH and is enriched at genes that are up-regulated in Rett syn- accumulates on Xi in domains with transcriptional activity, includ- drome (13, 14). ing the bodies of most genes that escape XCI and at the Mosaic XCI prevents discrimination of methylation on the X-inactivation center, validating this epigenetic mark as a signature active X chromosome (Xa) and Xi alleles by conventional of transcriptional activity. Escape genes showing CH hypermethy- methylome profiling. We reasoned that understanding the allele- lation were the only genes with CG-hypomethylated promoters on specific distribution of neuronal mCH in the context of X in- Xi, a well-known mark of active transcription. Finally, we found activation and imprinting could yield new insights into this extensive allele-specific mCH and mCG at autosomal imprinted unique aspect of the brain epigenome. Therefore, we profiled regions, some with a negative correlation between methylation allele-specific DNA methylation, as well as transcription, in in the two contexts, further supporting their distinct functions. mouse frontal cortex using a Xist mouse mutant hybrid in which Our findings show that neuronal mCH functions independently the paternal allele was deterministically inactivated in all cells of mCG and is a highly dynamic epigenomic correlate of allele- (8). To assign sequencing reads to alleles, we used female specific gene regulation. DNA methylation | X-chromosome inactivation | imprinting | Non-CG | Bcor Significance n diploid mammals, the equivalence of the two parental alleles Mammalian cells contain two copies of the genome inherited Iis violated by allele-specific epigenetic regulation in a small, from the two parents. Although most genes are expressed using but critical, subset of the genome. Genomic imprinting, or par- both, a small but critical part of the genome has different levels of ent-of-origin–dependent gene regulation (1), is critical for em- expression from each copy. These parts include the X chromosome in females and imprinted genes in both genders, which play key bryonic development and plays a role in neuronal differentiation roles in brain development and cognition. We measured gene (2). In females, epigenetic inactivation of one X chromosome expression and DNA methylation, an epigenetic modification of silences transcription of most genes to equalize gene expression the genome, in the brains of mice using a technique that allowed with males (3). Both imprinting and X-chromosome inactivation us to analyze the maternal and paternal copies of the genome (XCI) are critical to healthy brain development (4, 5). Despite separately. Our findings show that a brain-specific form of DNA the importance of allele-specific gene regulation in the brain, the methylation called non-CG methylation marks regions of active epigenetic mechanisms controlling these patterns are not com- transcription within the inactive X chromosome. pletely known, in part, due to the challenge of allele-specific epi- genomic profiling. In particular, DNA methylation patterns can Author contributions: C.L.K., C.M.D., J.R.E., and E.A.M. designed research; C.L.K., J.B.B., reflect allelic asymmetries in autosomal gene regulation (6), but R.C., J.R.N., C.M.D., and E.A.M. performed research; C.L.K., J.B.B., C.M.D., and E.A.M. contributed new reagents/analytic tools; C.L.K. and E.A.M. analyzed data; and C.L.K. their correlation with XCI has not been fully addressed. and E.A.M. wrote the paper. XCI has unique advantages as a case study for the investiga- The authors declare no conflict of interest. tion of allele-specific epigenomic regulation. The inactivated allele This article is a PNAS Direct Submission. P.D.S. is a Guest Editor invited by the Editorial is selected stochastically during early development and maintained Board. through subsequent cell divisions (7), yielding a mosaic pattern Freely available online through the PNAS open access option. of allelic expression in adult female tissues. Despite extensive Data deposition: The data reported in this paper have been deposited in the Gene Ex- inactivation of one X chromosome, some genes escape silencing pression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE83993). ∼ and are expressed from the inactive X chromosome (Xi): 3% of 1To whom correspondence should be addressed. Email: [email protected]. X-linked genes in mice (8) and 15% in humans (9). Analysis of This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. peripheral blood showed that XCI and escape from XCI are 1073/pnas.1611905114/-/DCSupplemental. E2882–E2890 | PNAS | Published online March 20, 2017 www.pnas.org/cgi/doi/10.1073/pnas.1611905114 Downloaded by guest on September 30, 2021 PNAS PLUS Iqsec2 Kdm5c A B Iqsec2 chrX: 152,069,000 - 152,335,000 Kantr Global mCG at promoters 25KB 75% C57/Spretus SNPs R1 69.7 69.0 Combined 50% R2 %mCG R1 25% 41.1 39.6 Xi 33.5 31.6 R2 31.4 mRNA 29.1 0 R1 Xa R2 Global mCG outside of promoters R1 2 1 75% Combined R2 85.2 85.6 85.5 85.3 84.9 84.9 75.6 75.7 R1 50% Xi %mCG R2 25% Xi hypo DMRs Xa hypo 0 mCG Methylation R1 Global mCH Xa 1.4% R2 Male X 1.26 1.24 1.23 1.0% 1.22 1.01 1.01 R1 Combined %mCH R2 0.4% R1 0.020 0 0.020 Xi R2R1 R2R1 R2R1 R2R1 R2 Maternal Paternal Xa Xi R1 Autosomes mCH Methylation Xa R2 Male X X Inactivation Center C Tsix Jpx Mir374c Cdx4 Chic1 Tsx Gm9159 Zcchc13 Xist Ftx chrX: 103,302,000 - 103,658,000 Mir374 25KB C57/Spretus SNPs R1 Combined R2 R1 Xi R2 mRNA R1 Xa R2 R1 1 23 Combined R2 R1 Xi R2 Xi Hypo DMRs Xa Hypo mCG Methylation R1 Xa R2 GENETICS Male X R1 Combined R2 R1 Xi R2 R1 Xa mCH Methylation R2 Male X Fig. 1. Ultrasparse mCH on Xi correlates with escape domains. (A) Allele-specific mCG and mCH levels on autosomes and chromosome X. Browser view of methylation and expression for the Kdm5c locus (B) and the XIC (C). Ticks show the methylation level at individual cytosine positions (CG, green; CH, blue) on the forward (upward ticks) and reverse (downward ticks) strands. Combined tracks show both alleles, whereas the Xa and Xi tracks include only reads sorted using SNPs between C57 and spretus. Monoallelically expressed genes (Iqsec2 and Chic1) and intergenic regions harbor mCH on Xa only, whereas diallelically expressed escape genes (Kdm5c) and the Xi-expressed noncoding RNA Xist contain dense mCH on Xi. Male X data are from 6-wk-old frontal cortex (11). chrX, chromosome X; R1, replicate 1; R2, replicate 2. Keown et al. PNAS | Published online March 20, 2017 | E2883 Downloaded by guest on September 30, 2021 F1 mice from crosses between C57BL/6 Xist mutant and Mus mCH on Xi presents an opposite (positive) correlation with tran- spretus wild-type mice (8), and analyzed species-specific genetic scription: Xi is remarkably void of mCH except in the gene body of variants (∼42 million single-nucleotide polymorphisms (SNPs), the escape gene, Kdm5c, where mCH is enriched (3.09%) and including 1.95 million SNPs on the X chromosome). Our data re- more abundant than on Xa (0.26%; P = 0.001).
Recommended publications
  • Identification and Characterization of TPRKB Dependency in TP53 Deficient Cancers
    Identification and Characterization of TPRKB Dependency in TP53 Deficient Cancers. by Kelly Kennaley A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Cellular Pathology) in the University of Michigan 2019 Doctoral Committee: Associate Professor Zaneta Nikolovska-Coleska, Co-Chair Adjunct Associate Professor Scott A. Tomlins, Co-Chair Associate Professor Eric R. Fearon Associate Professor Alexey I. Nesvizhskii Kelly R. Kennaley [email protected] ORCID iD: 0000-0003-2439-9020 © Kelly R. Kennaley 2019 Acknowledgements I have immeasurable gratitude for the unwavering support and guidance I received throughout my dissertation. First and foremost, I would like to thank my thesis advisor and mentor Dr. Scott Tomlins for entrusting me with a challenging, interesting, and impactful project. He taught me how to drive a project forward through set-backs, ask the important questions, and always consider the impact of my work. I’m truly appreciative for his commitment to ensuring that I would get the most from my graduate education. I am also grateful to the many members of the Tomlins lab that made it the supportive, collaborative, and educational environment that it was. I would like to give special thanks to those I’ve worked closely with on this project, particularly Dr. Moloy Goswami for his mentorship, Lei Lucy Wang, Dr. Sumin Han, and undergraduate students Bhavneet Singh, Travis Weiss, and Myles Barlow. I am also grateful for the support of my thesis committee, Dr. Eric Fearon, Dr. Alexey Nesvizhskii, and my co-mentor Dr. Zaneta Nikolovska-Coleska, who have offered guidance and critical evaluation since project inception.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Product Datasheet PBDC1 Antibody NBP1-82657
    Product Datasheet PBDC1 Antibody NBP1-82657 Unit Size: 0.1 ml Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NBP1-82657 Updated 6/7/2021 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NBP1-82657 Page 1 of 4 v.20.1 Updated 6/7/2021 NBP1-82657 PBDC1 Antibody Product Information Unit Size 0.1 ml Concentration Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services. Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Clonality Polyclonal Preservative 0.02% Sodium Azide Isotype IgG Purity Immunogen affinity purified Buffer PBS (pH 7.2) and 40% Glycerol Product Description Host Rabbit Gene ID 51260 Gene Symbol PBDC1 Species Human Reactivity Notes Immunogen displays the following percentage of sequence identity for non- tested species: Mouse (83%), Rat (85%) Immunogen This antibody was developed against Recombinant Protein corresponding to amino acids: EVYYKLISSVDPQFLKLTKVDDQIYSEFRKNFETLRIDVLDPEELKSESAKEKWR PFCLKFNGIVEDFNYGTLLRLDCSQGYTEENTIFAPRIQFFAIEIARNREGYNKAV YISVQDKEGEKGVNNGGEKRADSGEEENTKNGGEK Product Application Details Applications Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin Recommended Dilutions Western Blot 0.04 - 0.4 ug/ml,
    [Show full text]
  • MMP-25 Metalloprotease Regulates Innate Immune Response Through NF- Κb Signaling Clara Soria-Valles, Ana Gutiérrez-Fernández, Fernando G
    MMP-25 Metalloprotease Regulates Innate Immune Response through NF- κB Signaling Clara Soria-Valles, Ana Gutiérrez-Fernández, Fernando G. Osorio, Dido Carrero, Adolfo A. Ferrando, Enrique Colado, This information is current as M. Soledad Fernández-García, Elena Bonzon-Kulichenko, of September 27, 2021. Jesús Vázquez, Antonio Fueyo and Carlos López-Otín J Immunol 2016; 197:296-302; Prepublished online 3 June 2016; doi: 10.4049/jimmunol.1600094 Downloaded from http://www.jimmunol.org/content/197/1/296 Supplementary http://www.jimmunol.org/content/suppl/2016/06/01/jimmunol.160009 Material 4.DCSupplemental http://www.jimmunol.org/ References This article cites 41 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/197/1/296.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology MMP-25 Metalloprotease Regulates Innate Immune Response through NF-kB Signaling Clara Soria-Valles,* Ana Gutie´rrez-Ferna´ndez,* Fernando G.
    [Show full text]
  • Product Datasheet Cxorf26 Recombinant Protein Antigen NBP1
    Product Datasheet CXorf26 Recombinant Protein Antigen NBP1-82657PEP Unit Size: 0.1 ml Store at -20C. Avoid freeze-thaw cycles. Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NBP1-82657PEP Updated 11/3/2016 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NBP1-82657PEP Page 1 of 2 v.20.1 Updated 11/3/2016 NBP1-82657PEP CXorf26 Recombinant Protein Antigen Product Information Unit Size 0.1 ml Concentration Please see the vial label for concentration. If unlisted please contact technical services. Storage Store at -20C. Avoid freeze-thaw cycles. Preservative No Preservative Purity >80% by SDS-PAGE and Coomassie blue staining Buffer PBS and 1M Urea, pH 7.4. Target Molecular Weight 34 kDa Product Description Description A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human PBDC1. Source: E.coli Amino Acid Sequence: EVYYKLISSVDPQFLKLTKVDDQIYSEFRKNFETLRIDVLDPEELKSESAKEKWR PFCLKFNGIVEDFNYGTLLRLDCSQGYTEENTIFAPRIQFFAIEIARNREGYNKAV YISVQDKEGEKGVNNGGEKRADSGEEENTKNGGEK Gene ID 51260 Gene Symbol PBDC1 Species Human Product Application Details Applications Antibody Competition Recommended Dilutions Antibody Competition 10 - 100 molar excess Application Notes This peptide is useful as a blocking peptide for NBP1-82657.Protein was purified by IMAC chromatography. The expected concentration is greater than 0.5 mg/ml. This product is produced on demand, estimated
    [Show full text]
  • PRODUCT SPECIFICATION Anti-PBDC1 Product
    Anti-PBDC1 Product Datasheet Polyclonal Antibody PRODUCT SPECIFICATION Product Name Anti-PBDC1 Product Number HPA003155 Gene Description polysaccharide biosynthesis domain containing 1 Clonality Polyclonal Isotype IgG Host Rabbit Antigen Sequence Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: EVYYKLISSVDPQFLKLTKVDDQIYSEFRKNFETLRIDVLDPEELKSESA KEKWRPFCLKFNGIVEDFNYGTLLRLDCSQGYTEENTIFAPRIQFFAIEI ARNREGYNKAVYISVQDKEGEKGVNNGGEKRADSGEEENTKNGGEK Purification Method Affinity purified using the PrEST antigen as affinity ligand Verified Species Human Reactivity Recommended IHC (Immunohistochemistry) Applications - Antibody dilution: 1:200 - 1:500 - Retrieval method: HIER pH6 WB (Western Blot) - Working concentration: 0.04-0.4 µg/ml ICC-IF (Immunofluorescence) - Fixation/Permeabilization: PFA/Triton X-100 - Working concentration: 0.25-2 µg/ml Characterization Data Available at atlasantibodies.com/products/HPA003155 Buffer 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Concentration Lot dependent Storage Store at +4°C for short term storage. Long time storage is recommended at -20°C. Notes Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. For protocols, additional product information, such as images and references, see atlasantibodies.com. Product of Sweden. For research use only. Not intended for pharmaceutical development, diagnostic, therapeutic or any in vivo use. No products from Atlas Antibodies may be resold, modified for resale or used to manufacture commercial products without prior written approval from Atlas Antibodies AB. Warranty: The products supplied by Atlas Antibodies are warranted to meet stated product specifications and to conform to label descriptions when used and stored properly. Unless otherwise stated, this warranty is limited to one year from date of sales for products used, handled and stored according to Atlas Antibodies AB's instructions.
    [Show full text]
  • Engineered Type 1 Regulatory T Cells Designed for Clinical Use Kill Primary
    ARTICLE Acute Myeloid Leukemia Engineered type 1 regulatory T cells designed Ferrata Storti Foundation for clinical use kill primary pediatric acute myeloid leukemia cells Brandon Cieniewicz,1* Molly Javier Uyeda,1,2* Ping (Pauline) Chen,1 Ece Canan Sayitoglu,1 Jeffrey Mao-Hwa Liu,1 Grazia Andolfi,3 Katharine Greenthal,1 Alice Bertaina,1,4 Silvia Gregori,3 Rosa Bacchetta,1,4 Norman James Lacayo,1 Alma-Martina Cepika1,4# and Maria Grazia Roncarolo1,2,4# Haematologica 2021 Volume 106(10):2588-2597 1Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 2Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 3San Raffaele Telethon Institute for Gene Therapy, Milan, Italy and 4Center for Definitive and Curative Medicine, Stanford School of Medicine, Stanford, CA, USA *BC and MJU contributed equally as co-first authors #AMC and MGR contributed equally as co-senior authors ABSTRACT ype 1 regulatory (Tr1) T cells induced by enforced expression of interleukin-10 (LV-10) are being developed as a novel treatment for Tchemotherapy-resistant myeloid leukemias. In vivo, LV-10 cells do not cause graft-versus-host disease while mediating graft-versus-leukemia effect against adult acute myeloid leukemia (AML). Since pediatric AML (pAML) and adult AML are different on a genetic and epigenetic level, we investigate herein whether LV-10 cells also efficiently kill pAML cells. We show that the majority of primary pAML are killed by LV-10 cells, with different levels of sensitivity to killing. Transcriptionally, pAML sensitive to LV-10 killing expressed a myeloid maturation signature.
    [Show full text]
  • Allele-Specific Non-CG DNA Methylation Marks Domains Of
    Allele-specific non-CG DNA methylation marks domains PNAS PLUS of active chromatin in female mouse brain Christopher L. Keowna, Joel B. Berletchb, Rosa Castanonc, Joseph R. Neryc, Christine M. Distecheb,d, Joseph R. Eckerc,e, and Eran A. Mukamela,1 aDepartment of Cognitive Science, University of California, San Diego, CA 92037; bDepartment of Pathology, University of Washington, Seattle, WA 98195; cGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; dDepartment of Medicine, University of Washington, Seattle, WA 98195; and eHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037 Edited by Paul D. Soloway, Cornell University, Ithaca, NY, and accepted by Editorial Board Member Andrew G. Clark December 20, 2016 (received for review July 21, 2016) DNA methylation at gene promoters in a CG context is associated correlated with high or low levels of DNA methylation at CG with transcriptional repression, including at genes silenced on the dinucleotides (mCG) in promoter regions, respectively (10). How- inactive X chromosome in females. Non-CG methylation (mCH) is a ever, different epigenetic profiles may be associated with XCI and distinct feature of the neuronal epigenome that is differentially escape from XCI in the brain because the DNA methylation distributed between males and females on the X chromosome. landscape of neurons is distinct from other cell types. In particular, However, little is known about differences in mCH on the active neurons accumulate methylation at millions of genomic cytosines in (Xa) and inactive (Xi) X chromosomes because stochastic CA and CT dinucleotides during postnatal brain development be- X-chromosome inactivation (XCI) confounds allele-specific epige- ginning at 1 wk of age in mice (6, 11).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,892,798 B2 Pompejus Et Al
    US007892798B2 (12) United States Patent (10) Patent No.: US 7,892,798 B2 Pompejus et al. (45) Date of Patent: Feb. 22, 2011 (54) NUCLEICACID MOLECULES ENCODING (56) References Cited METABOLC REGULATORY PROTEINS U.S. PATENT DOCUMENTS FROM CORYNEBACTERIUM GLUTAMICUM, USEFUL FOR INCREASING THE 3,729,381 A 4, 1973 Nakayama et al. PRODUCTION OF METHONONE BY A 2005. O153402 A1 7/2005 Pompeius et al. MCROORGANISM FOREIGN PATENT DOCUMENTS (75) Inventors: Markus Pompeius, Freinsheim (DE); EP 1108790 A2 6, 2001 Burkhard Kröger, Limburgerhof (DE); EP 1108790 A2 * 6, 2001 Hartwig Schröder, Nussloch (DE); JP 50-31092 3, 1975 Oskar Zelder, Speyer (DE); Gregor WO WO-O2/O97096 A2 12/2002 Haberhauer, Limburgerhof (DE); OTHER PUBLICATIONS Stefan Haefner, Ludwigshafen (DE); Seffernicket al. J. Bateriol., vol. 183, pp. 2405-2410, 2001.* Corrinna Klopprogge, Ludwigshafen Branden et al. “Introduction to Protein Structure', Garland Publish (DE) ing Inc., New York, 1991, p. 247.* Witkowski et al., Biochemistry 38: 11643-11650, 1999.* (73) Assignee: Evonik Degussa GmbH, Essen (DE) Renna et al., J Bacteriol 175:3863-3875, 1993.* Dictionary definition of “positively at Encarta.com, last viewed on (*) Notice: Subject to any disclaimer, the term of this Jan. 16, 2008, 2 pages.* patent is extended or adjusted under 35 Kolmar et al., EMBO.J. 14:3895-3904, 1995.* U.S.C. 154(b) by 239 days. Hwang et al., J. Bacteriol. 184:1277-1286, 2002.* Belfaiza, J. et al. “Direct Sulfhydrylation for Methionine (21) Appl. No.: 10/307,138 Biosynthesis in Leptospira meyeri,’ Journal of Bacteriology, vol. 180(2):250-255 (1998). (22) Filed: Nov.
    [Show full text]
  • Cxorf26 (PBDC1) Mouse Monoclonal Antibody [Clone ID: OTI1F3] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA503238 CXorf26 (PBDC1) Mouse Monoclonal Antibody [Clone ID: OTI1F3] Product data: Product Type: Primary Antibodies Clone Name: OTI1F3 Applications: FC, IF, WB Recommended Dilution: WB 1:500, IF 1:100, FLOW 1:100 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Full length human recombinant protein of human CXorf26(NP_057584) produced in HEK293T cell. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 0.24 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 25.9 kDa Gene Name: polysaccharide biosynthesis domain containing 1 Database Link: NP_057584 Entrez Gene 51260 Human Q9BVG4 Synonyms: CXorf26 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 CXorf26 (PBDC1) Mouse Monoclonal Antibody [Clone ID: OTI1F3] – TA503238 Product images: HEK293T cells were transfected with the pCMV6- ENTRY control (Left lane) or pCMV6-ENTRY CXorf26 ([RC200095], Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CXorf26. Positive lysates [LY413940] (100ug) and [LC413940] (20ug) can be purchased separately from OriGene.
    [Show full text]
  • The Zinc Transporter Zip14 (Slc39a14) Affects Beta-Cell Function
    www.nature.com/scientificreports OPEN The zinc transporter Zip14 (SLC39a14) afects Beta-cell Function: Proteomics, Gene Received: 7 January 2019 Accepted: 24 May 2019 expression, and Insulin secretion Published: xx xx xxxx studies in INS-1E cells Trine Maxel1, Kamille Smidt2, Charlotte C. Petersen1, Bent Honoré1, Anne K. Christensen1, Per B. Jeppesen2,3, Birgitte Brock4, Jørgen Rungby5, Johan Palmfeldt2,6 & Agnete Larsen1 Insulin secretion from pancreatic beta-cells is dependent on zinc ions as essential components of insulin crystals, zinc transporters are thus involved in the insulin secretory process. Zip14 (SLC39a14) is a zinc importing protein that has an important role in glucose homeostasis. Zip14 knockout mice display hyperinsulinemia and impaired insulin secretion in high glucose conditions. Endocrine roles for Zip14 have been established in adipocytes and hepatocytes, but not yet confrmed in beta- cells. In this study, we investigated the role of Zip14 in the INS-1E beta-cell line. Zip14 mRNA was upregulated during high glucose stimulation and Zip14 silencing led to increased intracellular insulin content. Large-scale proteomics showed that Zip14 silencing down-regulated ribosomal mitochondrial proteins, many metal-binding proteins, and others involved in oxidative phosphorylation and insulin secretion. Furthermore, proliferation marker Mki67 was down-regulated in Zip14 siRNA-treated cells. In conclusion, Zip14 gene expression is glucose sensitive and silencing of Zip14 directly afects insulin processing in INS-1E beta-cells. A link between Zip14 and ribosomal mitochondrial proteins suggests altered mitochondrial RNA translation, which could disturb mitochondrial function and thereby insulin secretion. This highlights a role for Zip14 in beta-cell functioning and suggests Zip14 as a future pharmacological target in the treatment of beta-cell dysfunction.
    [Show full text]
  • Fatty Acid Metabolism Driven Mitochondrial Bioenergetics Promotes Advanced Developmental Phenotypes in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
    Fatty acid metabolism driven mitochondrial bioenergetics promotes advanced developmental phenotypes in human induced pluripotent stem cell derived cardiomyocytes Chrishan J.A. Ramachandra1,a,b, Ashish Mehta1,c, Philip Wonga,b,d,e*, K.P. Myu Mai Jaa, Regina Fritsche-Danielsonf, Ratan V. Bhatg, Derek J. Hausenloya,b,h,i,j, Jean-Paul Kovalikb and Winston Shima,b,k* aNational Heart Research Institute Singapore, National Heart Centre Singapore bCardiovascular & Metabolic Disorders Program, Duke-NUS Medical School, Singapore cPSC and Phenotyping Laboratory, Victor Chang Cardiac Research Institute, Sydney, Australia dDepartment of Cardiology, National Heart Centre Singapore eSchool of Materials Science and Engineering, Nanyang Technological University, Singapore fCardiovascular and Metabolic Disease Innovative Medicines and Early Development Unit, AstraZeneca Research and Development, Gothenburg, Sweden gStrategy and External Innovation Department, AstraZeneca, Gothenburg, Sweden hThe Hatter Cardiovascular Institute, University College London, United Kingdom iBarts Heart Centre, St Barthlomew’s Hospital, London, United Kingdom jYong Loo Lin School of Medicine, National University of Singapore kHealth and Social Sciences Cluster, Singapore Institute of Technology 1Both authors contributed equally Running title: Cardiomyocyte metabolism and bioenergetics *Corresponding authors: Philip Wong National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609 Email: [email protected]; Phone: +65 6704 8964; Fax: +65 6844 9053 Winston Shim
    [Show full text]